nach oben

Lung

Erschienen in:

14.07.2018 | COPD

Changes in the Burden of Comorbidities in Patients with COPD and Asthma–COPD Overlap According to the GOLD 2017 Recommendations

verfasst von: András Bikov, Alpár Horváth, Gábor Tomisa, Liza Bártfai, Zoltán Bártfai

Erschienen in: Lung | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Comorbidities associated with chronic obstructive pulmonary disease (COPD) affect quality of life and increase mortality. Asthma–COPD overlap (ACO) may express a different profile of comorbidities compared to COPD alone. It is unclear how recent changes in GOLD recommendations affect the profile of comorbidities in COPD and ACO.

Methods

Eight hundred and thirty-four patients with COPD were recruited from 67 Hungarian secondary care outpatient clinics, 469 of them had ACO. Comorbidities were defined by respiratory specialists based on medical history, patient report, and medications. COPD grades were defined according to the old 2016 and the new 2017 GOLD document. Comorbidities were compared along COPD ABCD groups determined by the old and new GOLD.

Results

66 and 72% of the COPD patients in groups C and D (GOLD 2016) were recategorized to groups A and B (GOLD 2017), respectively. There was no difference in the prevalence of disorders along the 2016 GOLD categories except for osteoporosis in ACO (p = 0.01). When the patients were categorized according to the 2017 GOLD criteria, the prevalence of osteoporosis (p = 0.01) was different among the four groups in all COPD patients. Subgroup analysis of non-ACO COPD patients revealed inter-group differences for cardiac arrhythmia (p < 0.01). No alteration was seen in the prevalence of coronary artery disease, hypertension, diabetes, or the total number of comorbidities.

Conclusion

A significant number of patients are recategorized according to the GOLD 2017 criteria. This change only marginally affects the profile of comorbidities; still this needs to be considered when assessing the patients in daily practice.

Global Initiative for Chronic Obstructive Lung Disease (2017) Available from: http://www.goldcopd.org

Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32(4):962–969. https://doi.org/10.1183/09031936.00012408 CrossRefPubMed

Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L (2014) The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J 43(4):993–1002. https://doi.org/10.1183/09031936.00065013 CrossRefPubMed

Park HJ, Leem AY, Lee SH, Song JH, Park MS, Kim YS, Kim SK, Chang J, Chung KS (2015) Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chronic Obstr Pulm Dis 10:1571–1582. https://doi.org/10.2147/copd.s85767 CrossRef

Buch P, Friberg J, Scharling H, Lange P, Prescott E (2003) Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 21(6):1012–1016CrossRefPubMed

Konecny T, Park JY, Somers KR, Konecny D, Orban M, Soucek F, Parker KO, Scanlon PD, Asirvatham SJ, Brady PA, Rihal CS (2014) Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol 114(2):272–277. https://doi.org/10.1016/j.amjcard.2014.04.030 CrossRefPubMed

Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Aida Y, Nunomiya K, Nemoto T, Sato M, Konta T, Kawata S, Kato T, Kayama T, Kubota I (2011) Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 8(7):514–522CrossRefPubMedPubMedCentral

Jones PW, Nadeau G, Small M, Adamek L (2014) Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med 108(1):129–135. https://doi.org/10.1016/j.rmed.2013.08.015 CrossRefPubMed

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Calle-Rubio M, Solanes-Garcia I, Aguero R, de Diego-Damia A, Feu-Collado N, Alfageme I, Irigaray R, Balcells E, Llunell A, Galdiz JB, Marin M, Soler-Cataluna JJ, Lopez-Campos JL, Soriano JB, de-Torres JP (2014) New GOLD classification: longitudinal data on group assignment. Respir Res 15:3. https://doi.org/10.1186/1465-9921-15-3 CrossRefPubMedPubMedCentral

10.

Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluna JJ, van der Molen T, Adamek L, Banik N (2011) Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 105(1):57–66. https://doi.org/10.1016/j.rmed.2010.09.004 CrossRefPubMed

11.

Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122. https://doi.org/10.1186/1465-9921-11-122 CrossRefPubMedPubMedCentral

12.

Battaglia S, Basile M, Scichilone N, Bellia V (2015) Prevalence of co-morbidities and severity of COPD. COPD 12(4):390–394. https://doi.org/10.3109/15412555.2014.974734 CrossRefPubMed

13.

Cabrera Lopez C, Casanova Macario C, Marin Trigo JM, de-Torres JP, Sicilia Torres R, Gonzalez JM, Polverino F, Divo M, Pinto Plata V, Zulueta JJ, Celli B (2018) Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports. Impact on grouping and outcomes. Am J Respir Crit Care Med 197(4):463–469. https://doi.org/10.1164/rccm.201707-1363OC CrossRefPubMed

14.

Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth F, Vestbo J, Wouters EF, Vogelmeier CF, Jorres RA (2018) The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 134:79–85. https://doi.org/10.1016/j.rmed.2017.12.003 CrossRefPubMed

15.

Global Initiative for Asthma (2017) Global strategy for asthma management and prevention, Available from: http://www.ginasthma.org

16.

Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, Donohue JF, Herrick HL (2014) Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD 11(3):256–266. https://doi.org/10.3109/15412555.2013.840571 CrossRefPubMed

17.

Nielsen M, Barnes CB, Ulrik CS (2015) Clinical characteristics of the asthma-COPD overlap syndrome—a systematic review. Int J Chronic Obstr Pulm Dis 10:1443–1454. https://doi.org/10.2147/copd.s85363 CrossRef

18.

Agusti A, Hurd S, Jones P, Fabbri LM, Martinez F, Vogelmeier C, Vestbo J, Rodriguez-Roisin R (2013) FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J 42(5):1391–1401. https://doi.org/10.1183/09031936.00036513 CrossRefPubMed

19.

Horvath A, Tomisa G, Meszaros A, Barfai L, Bartfai Z (2017) Assessing the characteristics of patients with COPD and asthma-COPD overlap syndrome within the framework of a real-life prospective study. Med Thoracalis 70(1):53–62

20.

Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, Somfay A, Zykov K, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Tkacova R (2017) GOLD 2017 on the way to a phenotypic approach? Analysis from the phenotypes of COPD in Central and Eastern Europe (POPE) Cohort. Eur Respir J. https://doi.org/10.1183/13993003.02518-2016 CrossRefPubMedPubMedCentral

21.

Okazaki R, Watanabe R, Inoue D (2016) Osteoporosis associated with chronic obstructive pulmonary disease. J Bone Metab 23(3):111–120. https://doi.org/10.11005/jbm.2016.23.3.111 CrossRefPubMedPubMedCentral

22.

Sakurai-Iesato Y, Kawata N, Tada Y, Iesato K, Matsuura Y, Yahaba M, Suzuki T, Ikari J, Yanagawa N, Kasahara Y, West J, Tatsumi K (2017) The relationship of bone mineral density in men with chronic obstructive pulmonary disease classified according to the global initiative for chronic obstructive lung disease (GOLD) combined chronic obstructive pulmonary disease (COPD) assessment system. Intern Med 56(14):1781–1790. https://doi.org/10.2169/internalmedicine.56.6910 CrossRefPubMedPubMedCentral

23.

Raluy-Callado M, Lambrelli D, MacLachlan S, Khalid JM (2015) Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Int J Chronic Obstr Pulm Dis 10:925–937. https://doi.org/10.2147/copd.s82064 CrossRef

24.

Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Mullerova H, Lomas DA, Wouters E, Bakke P, Rennard S, Crim C, Miller BE, Coxson HO, Yates JC, Tal-Singer R, Vestbo J (2013) Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 42(3):636–646. https://doi.org/10.1183/09031936.00195212 CrossRefPubMed

25.

Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW, Anzueto A, Martinez FJ, Crapo JD, Silverman EK, Make BJ (2013) GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 1(1):43–50. https://doi.org/10.1016/s2213-2600(12)70044-9 CrossRefPubMed

26.

Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR (2017) Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res 18(1):31. https://doi.org/10.1186/s12931-017-0512-2 CrossRefPubMedPubMedCentral

27.

Miyazaki M, Nakamura H, Chubachi S, Sasaki M, Haraguchi M, Yoshida S, Tsuduki K, Shirahata T, Takahashi S, Minematsu N, Koh H, Nakamura M, Sakamaki F, Terashima T, Sayama K, Jones PW, Asano K, Betsuyaku T (2014) Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res 15:13. https://doi.org/10.1186/1465-9921-15-13 CrossRefPubMedPubMedCentral

28.

Slats A, Taube C (2016) Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma? Ther Adv Respir Dis 10(1):57–71. https://doi.org/10.1177/1753465815617082 CrossRefPubMed

29.

Postma DS, Rabe KF (2015) The Asthma-COPD overlap syndrome. N Engl J Med 373(13):1241–1249. https://doi.org/10.1056/NEJMra1411863 CrossRefPubMed

30.

Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svancara J, Sorli J, Krams A, Miravitlles M, Valipour A (2017) Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J. https://doi.org/10.1183/13993003.01446-2016 CrossRefPubMedPubMedCentral

31.

Ekerljung L, Mincheva R, Hagstad S, Bjerg A, Telg G, Stratelis G, Lotvall J (2018) Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample. J Asthma 55(5):461–469. https://doi.org/10.1080/02770903.2017.1339799 CrossRefPubMed

32.

Kumbhare S, Pleasants R, Ohar JA, Strange C (2016) Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc 13(6):803–810. https://doi.org/10.1513/AnnalsATS.201508-554OC CrossRefPubMed

33.

Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, Haahtela T, Laitinen T (2011) Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 48(3):279–285. https://doi.org/10.3109/02770903.2011.555576 CrossRefPubMed

34.

Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, Fushimi K, Nagase T (2015) Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology 20(6):940–946. https://doi.org/10.1111/resp.12556 CrossRefPubMed

35.

van Boven JF, Roman-Rodriguez M, Palmer JF, Toledo-Pons N, Cosio BG, Soriano JB (2016) Comorbidome, pattern, and impact of Asthma-COPD overlap syndrome in real life. Chest 149(4):1011–1020. https://doi.org/10.1016/j.chest.2015.12.002 CrossRefPubMed

36.

Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T (2013) High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 7(4):342–346. https://doi.org/10.1111/crj.12013 CrossRefPubMed

37.

Lucke T, Herrera R, Wacker M, Holle R, Biertz F, Nowak D, Huber RM, Sohler S, Vogelmeier C, Ficker JH, Muckter H, Jorres RA (2016) Systematic analysis of self-reported comorbidities in large cohort studies—a novel stepwise approach by evaluation of medication. PLoS One 11(10):e0163408. https://doi.org/10.1371/journal.pone.0163408 CrossRefPubMedPubMedCentral

Titel: Changes in the Burden of Comorbidities in Patients with COPD and Asthma–COPD Overlap According to the GOLD 2017 Recommendations
verfasst von: András Bikov
Alpár Horváth
Gábor Tomisa
Liza Bártfai
Zoltán Bártfai
Publikationsdatum: 14.07.2018
Verlag: Springer US
Erschienen in: Lung / Ausgabe 5/2018
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-018-0141-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Changes in the Burden of Comorbidities in Patients with COPD and Asthma–COPD Overlap According to the GOLD 2017 Recommendations

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Ventilator Weaning: How Far from the Final Quantum Leap?

Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome

Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis

Ventilator Weaning and Excursion Time Index: One Step Closer to the Quantum Leap?

Prediction of Post-operative Morbidity and Mortality in Patients with Lung Cancer: Methodological Issues

Strategies for the Integration of Cough and Swallow to Maintain Airway Protection in Humans

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin